Myovant Sciences helps women with uterine fibroids and endometriosis and men with prostate cancer by developing new medicines.
stop loss at the red line
Comment:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
